Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCAT2 | O15382 | 1/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.57 |
| ▸ | NPC1 | O15118 | 4/20 | 0.57 |
| ▸ | RAB9A | P51151 | 4/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.53 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.53 |
| ▸ | AOC3 | Q16853 | 3/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7460922 | 0.84 | BCAT2 (0.47) | BCAT2SMN1; SMN2NPC1RAB9ALMNA | |
| SCHEMBL7476838 | 0.84 | BCAT2 (0.47) | BCAT2SMN1; SMN2NPC1RAB9ALMNA | |
| SCHEMBL7466916 | 0.83 | ADRB3 (0.48) | BCAT2CYP1A2CYP2D6 | |
| SCHEMBL7466075 | 0.83 | ADRB3 (0.48) | BCAT2CYP1A2CYP2D6 | |
| SCHEMBL7474893 | 0.83 | ADRB3 (0.48) | BCAT2CYP1A2CYP2D6 | |
| SCHEMBL8047567 | 0.81 | SMN1; SMN2 (0.64) | BCAT2SMN1; SMN2NPC1RAB9ALMNA | |
| SCHEMBL3507313 | 0.81 | BCAT2 (1.00) | BCAT2SMN1; SMN2NPC1RAB9ALMNA | |
| SCHEMBL7465481 | 0.79 | ADRB1 (0.50) | BCAT2SMN1; SMN2NPC1RAB9ALMNA | |
| SCHEMBL2904416 | 0.79 | ADRB1 (0.50) | BCAT2SMN1; SMN2NPC1RAB9ALMNA | |
| SCHEMBL7470205 | 0.79 | ADRB1 (0.50) | BCAT2SMN1; SMN2NPC1RAB9ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1406605-B1 | CARBAMATES OF 2-HETEROCYCLIC-1,2-ETHANEDIOLS | SK CORP (KR) | 2007-09-19 | — | — | EP | disclosed |
| EP-1406605-A4 | CARBAMATES OF 2-HETEROCYCLIC-1,2-ETHANEDIOLS | SK CORP (KR) | 2005-10-26 | — | — | EP | disclosed |
| US-20050065193-A1 | Carbamates of 2-heterocyclic-1,2-ethanediols | SK CORPORATION | 2005-03-24 | — | — | US | disclosed |
| US-6841569-B2 | Carbamates of 2-heterocyclic-1,2-ethanediols | SK CORPORATION (US) | 2005-01-11 | — | — | US | disclosed |
| EP-1406605-A1 | CARBAMATES OF 2-HETEROCYCLIC-1,2-ETHANEDIOLS | SK Corporation (KR) | 2004-04-14 | — | — | EP | disclosed |
| US-20030078235-A1 | Carbamates of 2-heterocyclic-1,2-ethanediols | SK BIOPHARMACEUTICALS CO., LTD. (KR) | 2003-04-24 | — | — | US | disclosed |
| WO-2003000247-A1 | CARBAMATES OF 2-HETEROCYCLIC-1,2-ETHANEDIOLS | SK CORPORATION (KR) | 2003-01-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050065193-A1 | Carbamates of 2-heterocyclic-1,2-ethanediols | CNR2, CNR1, GRIN2C | BCAT2 840/4885SMN1; SMN2 916/4885NPC1 1500/4885 |
| US-20030078235-A1 | Carbamates of 2-heterocyclic-1,2-ethanediols | CNR2, CNR1, GRIN2C | BCAT2 840/4885SMN1; SMN2 916/4885NPC1 1500/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.